Therefore, more attainable biological samples, such as the blood, would represent a more suitable alternative for the study of MFSD2a and many other molecules that may be used as proteomic biomarkers for the clinical evaluation of gestational diabetes mellitus (35). This evidence concerns the gene MFSD2A and gestational diabetes.